Evidence for multiple-antibiotic resistance in Campylobacter jejuni not mediated by CmeB or CmeF

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 4, 2005, Pages 1289-1293

  Pumbwe, Lilian ^a   Randall, Luke P ^b   Woodward, Martin J ^b   Piddock, Laura J V ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b VETERINARY LABORATORIES AGENCY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIDINE ORANGE; AGAR; AMPICILLIN; ANTIBIOTIC AGENT; CARRIER PROTEIN; CETRIMIDE; CHLORAMPHENICOL DERIVATIVE; CIPROFLOXACIN; DEOXYCHOLIC ACID; DODECYL SULFATE SODIUM; ERYTHROMYCIN; ETHIDIUM BROMIDE; OUTER MEMBRANE PROTEIN; PORIN A; PROTEIN CMEB; PROTEIN CMEF; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; TRICLOSAN; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIUM CULTURE; CAMPYLOBACTER JEJUNI; CULTURE MEDIUM; DRUG EXPOSURE; GENE EXPRESSION; GENE MUTATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

ANTI-INFECTIVE AGENTS; BACTERIAL OUTER MEMBRANE PROTEINS; CAMPYLOBACTER JEJUNI; CIPROFLOXACIN; DNA GYRASE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; MUTATION;

EID: 16244387902     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.4.1289-1293.2005     Document Type: Article

References (33)

1. Aarestrup, F. M., and J. Engberg. 2001. Antimicrobial resistance of thermophilic Campylobacter. Vet. Res. 32:311-321.
2. Allos, B. M. 2001. Campylobacter jejuni infections: update on emerging issues and trends. Clin. Infect. Dis. 32:1201-1206.
3. Arnoud, H., M. Van Vliet, A. C. Wood, J. Henderson, K. Wooldridge, and J. M. Ketley. 1998. Genetic manipulation of enteric Campylobacter species. Methods Microbiol. 27:407-421.
4. Borges-Wamsley, M. I., and A. R. Walmsley. 2001. The structure and function of drug pumps. Trends Microbiol. 9:71-79.
5. Charvalos, E., Y. Tselentis, M. M. Hamzehpour, T. Kohler, and J. C. Pechere. 1995. Evidence for an efflux pump in multidrug-resistant Campylobacter jejuni. Antimicrob. Agents Chemother. 39:2019-2022.
6. Eaves, D. J. V., V. Ricci, and L. J. V. Piddock. 2004. Expression of acrB, acrF, acrB, marA and soxS in Salmonella enterica serovar Typhimirium: role in multiple antibiotic resistance. Antimicrob. Agents Chemother. 48:1145-1150.
7. Eaves, D. J. V., E. Liebana, M. J. Woodward, and L. J. V. Piddock. 2002. Detection of gyrA mutations in quinolone-resistant Salmonella enterica by denaturing high-performance liquid chromatography. J. Clin. Microbiol. 40:4121-4125.
8. Enberg, J., F. M. Aarestrup, D. E. Taylor, P. Gerner-Smidt, and I. Nachamkin. 2001. Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates. Emerg. Infect. Dis. 7:24-34.
9. Everett, M., Y. F. Jin, V. Ricci, and L. J. V. Piddock. 1996. Contribution of individual mechanisms to fluoroquinolone resistance in Escherichia coli strains isolated from humans and animals. Antimicrob. Agents Chemother. 40:2380-2386.
10. Gaunt, P. N., and L. J. V. Piddock. 1996. Ciprofloxacin resistant Campylobacter spp. in humans: an epidemiological and laboratory study. J. Antimicrob. Chemother. 37:47-57.
11. Griggs, D. J., H. Marona, and L. J. V. Piddock. 2003. Selection of moxifloxacin-resistant Staphylococcus aureus compared with five other fluoroquinolones. J. Antimicrob. Chemother. 51:1403-1407.
12. Jagannathan, A., C. Constantinidou, and C. Penn. 2001. Roles of rpoN, fliA, and flgR in expression of flagella in Campylobacter jejuni. J. Bacteriol. 183:2937-2942.
13. Kohler, T., J. C. Pechere, and P. Plesiat. 1999. Bacterial antibiotic efflux systems of medical importance. Cell. Mol. Life Sci. 56:771-778.
14. Labesse, G., E. S. Garnotel, S. Bonnel, G. Pumas, J. M. Pages, and J. M. Bola. 2001. MOMP, a divergent porin from Campylobacter: cloning and primary structural characterization. Biochem. Biophys. Res. Commun. 280:380-387.
15. Lin, J., L. O. Michel, and Q. Zhang. 2002. CmeABC functions as a multidrug efflux system in Campylobacter jejuni. Antimicrob. Agents Chemother. 46:2124-2131.
16. Lin, J., O. Sahin, L. O. Michel, and Q. Zhang. 2003. Critical role of the multidrug efflux pump CmeABC in bile resistance and in vivo colonization of Campylobacter jejuni. Infect. Immun. 8:4250-4259.
17. Livermore, D. M., D. James, M. Reacher, C. Graham, T. Nichols, P. Stephens, A. P. Johnson, and R. C. George. 2002. Trends in fluoroquinolone (ciprofloxacin) resistance in Enterobacteriaceae from bacteremias, England and Wales, 1990-1999. Emerg. Infect. Dis. 8:473-478.
18. Luo, N., O. Shahin, J. Lin, L. O. Michel, and Q. Zhang. 2003. In vivo selection of Campylobacter isolates with high-level fluoroquinolone resistance associated with gyrA mutations and the function of the CmeABC efflux pump. Antimicrob. Agents Chemother. 47:390-394.
19. Markham, P., E. Westhause, K. Klyachko, M. E, Johnson, and A. A. Neyfakh. 1999. Multiple novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus. Antimicrob. Agents Chemother. 43:2404-2408.
20. Markham, P. N., and A. A. Neyfakh. 1996. Inhibition of the multidrug transporter NorA prevents emergence of norfloxacin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 406:2673-2674.
21. Murakami, S., R. Nakashima, E. Yamashita, and A. Yamaguchi. 2002. Crystal structure of bacterial multidrug efflux transporter AcrB. Nature 419:587-593.
22. Nachamkin, I., H. Ung, and M. Li. 2003. Increasing fluoroquinolone resistance in Campylobacter jejuni, Pennsylvania, USA, 1982-2001. Emerg. Infect. Dis. 8:1501-1503.
23. NCCLS. 2002. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A5. National Committee for Clinical Laboratory Standards, Villanova, Pa.
24. Nikaido, H., and H. I. Zgurskaya. 2001. AcrAB and related multidrug efflux pumps in Escherichia coli. J. Mol. Microbiol. Biotechnol. 3:215-218.
25. Oethinger, M., W. V. Kern, A. S. Jellen-Ritter, L. M. McMurry, and S. B. Levy. 2000. Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump. Antimicrob. Agents Chemother. 44:10-13.
26. Parkhill, J., B. W. Wren, K. Mungall, J. M. Ketley, C. Churcher, D. Basham, T. Chillingworth, R. M. Davies, T. Feltwell, S. Holroyd, K. Jagels, A. V. Karleyshev, S. Moule, M. J. Pallen, C. W. Penn, M. A. Quail, M. A. Rajandream, K. M. Rutherford, A. H. Van Vliet, S. Whitehead, and B. G. Barrell. 2000. The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature 403:665-668.
27. Payot, S., A Cloeckaert, and E. Chalus-Dancla. 2002. Selection and characterization of fluoroquinolone resistant mutants of Campylobacter jejuni using enrofloxacin. Microb. Drug Resist. 84:335-343.
28. Piddock, L. J. V., V. Ricci, L. Pumbwe, M. J. Everett, and D. J. G. Griggs. 2003. Fluoroquinolone resistance in Campylobacter species from man and animals: detection of mutations in topoisomerase genes. J. Antimicrob. Chemother. 51:19-26.
29. Poole, K. 2001. Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms. J. Mol. Microbiol. Biotechnol. 3:255-264.
30. Pumbwe, L., and L. J. V. Piddock. 2002. Identification and molecular characterisation of CmeB, a Campylobacter jejuni multidrug efflux pump. FEMS Microbiol. Lett. 206:185-189.
31. Pumbwe, L., L. P. Randall, M. J. Woodward, and L. J. V. Piddock. 2004. Expression of the efflux pump genes cmeB, cmeF and the porin gene porA in multiple antibiotic resistant isolates of Campylobacter jejuni. J. Antimicrob. Chemother. 54:341-347.
32. Thwaites, R. T., and J. A. Frost. 1999. Drug resistant Campylobacter jejuni, C. coli and C. lari isolated from humans in North West England and Wales in 1997. J. Clin. Pathol. 52:812-814.
33. Wang, Y., and D. E. Taylor. 1990. Chloramphenicol resistance in Campylobacter coli: nucleotide sequence, expression and cloning vector construction. Gene 94:23-28.